Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ANTXANTX
18 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in AN2 THERAPEUTICS INC

CITADEL ADVISORS LLC holds 951,997 shares of ANTX (AN2 THERAPEUTICS INC), worth $4.6M as of 2026-Q2. The position was increased (+513.3% shares). ANTX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.6M

Current Shares

951,997

Total Value Change

-$16M

Total Shares Change

-467,854

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
951,997
+513.3%
$4.6M0.0%$4.84
43
2026-Q1
Increased
155,239
+34.4%
$530,9170.0%$1.06
31
2025-Q4
Increased
115,536
+402.1%
$131,7110.0%$1.08
24
2025-Q3
Increased
23,013
+84.2%
$29,2270.0%$1.28
21
2025-Q2
New
12,497
-
$13,2470.0%$1.08
27
2025-Q1
Exited
0
-100.0%
$00.0%$1.39
0
2024-Q4
New
67,994
-
$93,8320.0%$1.41
33
2024-Q3
Exited
0
-100.0%
$00.0%$1.06
0
2024-Q2
Decreased
1.6M
-0.2%
$3.3M0.0%$2.15
0
2024-Q1
Decreased
1.6M
-0.0%
$5.1M0.0%$3.25
0
2023-Q4
Increased
1.6M
+0.0%
$31.9M0.0%$20.49
29
2023-Q3
Increased
1.6M
+16.4%
$25M0.0%$16.08
33
2023-Q2
Decreased
1.3M
-0.0%
$11.4M0.0%$8.40
0
2023-Q1
Increased
1.3M
+0.0%
$13.2M0.0%$9.63
28
2022-Q4
Unchanged
1.3M
0.0%
$12.7M0.0%$9.53
0
2022-Q3
Increased
1.3M
+0.2%
$23.2M0.0%$15.32
29
2022-Q2
Decreased
1.3M
-6.1%
$9.9M0.0%$7.91
0
2022-Q1
New
1.4M
-
$20.6M0.0%$15.00
39

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used